Thomas Wurdinger

Cancer is a leading cause of death in dogs, just as it is in humans. At Benno Therapeutics, we have found ways to significantly increase survival rates, without the typical side-effects of more traditional cancer treatments. Listen to our story on Spotify or Apple Music (search for Bennos song)

ABOUT CELLAB Cellab CDMO is a Contract Development and Manufacturing Organization (CDMO) specialized in cell and gene therapy. Our team has a decade of expertise in ATMP manufacturing and GMP processes, we specialize in collaborating closely with small teams to advance ATMPs from basic research to early clinical trials. We partner closely with our clients, acting as an extension of their team to accelerate the journey from bench to bedside. Our agile approach allows us to adapt quickly to evolving project needs, ensuring timely delivery and success. With a focus on quality, integrity, and innovation, we are committed to delivering excellence in every aspect of ATMP development. WHY US Cellab CDMO provides top-tier collaboration services, guaranteeing GMP compliance across the entire drug development. By working closely with our clients and adopting a flexible and collaborative approach, we ensure a successful and less risky outcome for your ATMP development project. Our aim is to navigate you from your present state to your envisioned future set up, offering tailored solutions to align with your objectives within a structured timeline, spanning from R&D to GMP production of your ATMP. SERVICES We offer a broad range of services, tailored made and highly adaptable to the clients need. It includes bioprocess scaling design from R&D to GMP, ATMP manufacturing, GMP batch release, GMP storage area, among others.

Neurocast is the True Passive Patient monitoring solution: We turn everyday daily digital interactions, such as smartphone use, into medically approved outcomes, enabling everyone to gain insight into their brain health - anytime, anywhere & without any effort. By doing so, all healthcare stakeholders benefit.  

CimCure’s solution is a vaccination based immunotherapy directed to the tumor blood vessels that are common to most solid tumors.

Omnio AB is a biopharmaceutical company dedicated to revolutionizing the treatment of diabetic foot ulcers (DFUs) through the development of recombinant plasminogen therapeutics.

Cancer is a leading cause of death in dogs, just as it is in humans. At Benno Therapeutics, we have found ways to significantly increase survival rates, without the typical side-effects of more traditional cancer treatments. Listen to our story on Spotify or Apple Music (search for Bennos song)

ABOUT CELLAB Cellab CDMO is a Contract Development and Manufacturing Organization (CDMO) specialized in cell and gene therapy. Our team has a decade of expertise in ATMP manufacturing and GMP processes, we specialize in collaborating closely with small teams to advance ATMPs from basic research to early clinical trials. We partner closely with our clients, acting as an extension of their team to accelerate the journey from bench to bedside. Our agile approach allows us to adapt quickly to evolving project needs, ensuring timely delivery and success. With a focus on quality, integrity, and innovation, we are committed to delivering excellence in every aspect of ATMP development. WHY US Cellab CDMO provides top-tier collaboration services, guaranteeing GMP compliance across the entire drug development. By working closely with our clients and adopting a flexible and collaborative approach, we ensure a successful and less risky outcome for your ATMP development project. Our aim is to navigate you from your present state to your envisioned future set up, offering tailored solutions to align with your objectives within a structured timeline, spanning from R&D to GMP production of your ATMP. SERVICES We offer a broad range of services, tailored made and highly adaptable to the clients need. It includes bioprocess scaling design from R&D to GMP, ATMP manufacturing, GMP batch release, GMP storage area, among others.

Neurocast is the True Passive Patient monitoring solution: We turn everyday daily digital interactions, such as smartphone use, into medically approved outcomes, enabling everyone to gain insight into their brain health - anytime, anywhere & without any effort. By doing so, all healthcare stakeholders benefit.  

CimCure’s solution is a vaccination based immunotherapy directed to the tumor blood vessels that are common to most solid tumors.

Omnio AB is a biopharmaceutical company dedicated to revolutionizing the treatment of diabetic foot ulcers (DFUs) through the development of recombinant plasminogen therapeutics.